Facebook
Instagram
Linkedin
Youtube
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Search
BioStock
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Home
Tags
INITIUM
Tag: INITIUM
Ultimovacs’ malignant melanoma study fully recruited
1 July, 2022
Ultimovacs to ride wave of positive momentum in 2022
22 February, 2022
Ultimovacs’ UV1 granted orphan drug designation
7 December, 2021
Ultimovacs receives dual FDA Fast Track for UV1
22 October, 2021
Ultimovacs strengthens clinical validation of UV1 in Q2
25 August, 2021
Ultimovacs on track to develop universal cancer vaccine
24 September, 2020